At December 31, 2025, two customers of LCT (inclusive of the aforementioned customer) individually accounted for more than 10% of accounts receivable, net and in the aggregate accounted for 64% of ac…
International Stem Cell Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
ISCO-DEBT-10372
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2019-12-31.
ISCO-DEBT
Debt stack $3.5M
90%
Market cache reports total debt of $3.5M.
ISCO-DEBT-10371
Warrants outstanding: 127508118
90%
xbrl warrant detail from xbrl 2020-12-31.
International Stem Cell Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for International Stem Cell Corporation.
International Stem Cell Corporation Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for International Stem Cell Corporation.
International Stem Cell Corporation Extended Supply Chain Network